CLINICAL TRIALS PROFILE FOR METHAMPHETAMINE HYDROCHLORIDE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for methamphetamine hydrochloride
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| OTC | NCT00829634 ↗ | Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation | Completed | National Institutes of Health (NIH) | N/A | 2008-10-01 | The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine. |
| OTC | NCT00829634 ↗ | Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation | Completed | San Francisco General Hospital | N/A | 2008-10-01 | The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine. |
| OTC | NCT00829634 ↗ | Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation | Completed | University of California, San Francisco | N/A | 2008-10-01 | The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine. |
| OTC | NCT00829634 ↗ | Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation | Completed | California Pacific Medical Center Research Institute | N/A | 2008-10-01 | The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine. |
| OTC | NCT01736332 ↗ | Factors Affecting Methamphetamine and Opiates Drug Testing | Completed | National Institute on Drug Abuse (NIDA) | Phase 1 | 2012-07-19 | Background: - Some legal over-the-counter drugs (such as Vicks VapoInhaler ) and some foods (such as poppy seeds) may cause a positive screening drug test. This might look like someone used illegal drugs (such as methamphetamines or opiates) when they did not. Researchers are studying how the body handles chemicals that may test like illegal drugs and for how long they may be detected in the body. Blood, saliva, and urine samples will be collected. This study may help improve the effectiveness and accuracy of drug tests. Objectives: - To see how the body handles chemicals that may produce positive screening tests and how additional testing can eliminate positive drug tests from over-the-counter drugs and food. Eligibility: - Healthy volunteers between 18 and 65 years of age. Design: - Participants are screened with a physical exam, medical history, laboratory tests, and ECG. - This study involves an overnight stay on a secure research unit and 2 days of tests. - On the first day, participants will take Vicks VapoInhaler (two inhalations in each nostril) every 2 hours from 9 a.m. to 7 p.m. They will also take a drink containing poppy seeds twice (at about 9 a.m. and 5 p.m.). - On the morning of the second day, participants will take the Vicks VapoInhaler just once. They will be discharged around 5 p.m. - On both days, participants will provide blood and saliva samples several times throughout the day. All of their urine will be collected during the 2 study days.... |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for methamphetamine hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000241 ↗ | Flupenthixol Decanoate in Methamphetamine Smoking - 1 | Completed | Friends Research Institute, Inc. | Phase 2 | 1994-02-01 | The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration. |
| NCT00000241 ↗ | Flupenthixol Decanoate in Methamphetamine Smoking - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1994-02-01 | The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration. |
| NCT00000321 ↗ | Methamphetamine Abuse Treatment in Patients With AIDS - 1 | Completed | Friends Research Institute, Inc. | Phase 4 | 1996-10-01 | The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS. |
| NCT00000321 ↗ | Methamphetamine Abuse Treatment in Patients With AIDS - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 4 | 1996-10-01 | The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS. |
| NCT00000340 ↗ | Pemoline in the Treatment of Stimulant Dependence - 5 | Withdrawn | National Institute on Drug Abuse (NIDA) | Phase 2 | 1996-06-01 | The purpose of this study is to assess the efficacy of pemoline in treating cocaine and/or methamphetamine dependent adults with comorbid Adult Attention Deficit Hyperactivity Disorder (ADHD). |
| NCT00033072 ↗ | Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1 | Unknown status | National Institute on Drug Abuse (NIDA) | Phase 1 | 2001-09-01 | The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for methamphetamine hydrochloride
Condition Name
Clinical Trial Locations for methamphetamine hydrochloride
Trials by Country
Clinical Trial Progress for methamphetamine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for methamphetamine hydrochloride
Sponsor Name
